Latest stories on SVA
Sinovac Posts Wider H1 2026 Loss as Overseas Vaccine Sales and New Approvals Reshape Growth Mix
TipRanks38 · neutralearnings
Sinovac Biotech reports 1H EPS (84c) vs. (30c) last year
The Fly67 · bullishearnings
SINOVAC Reports Unaudited First Half of 2026 Financial Results
StockTitan34 · bearishearnings
Sinovac Regains Nasdaq Listing Compliance After Filing Delayed Annual Report
TipRanks59 · neutralgeneral
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements | SVA Stock News
StockTitan55 · neutralgeneral
Sinovac Posts 2025 Net Loss Amid Asset Impairments As Overseas Vaccine Sales Surge
TipRanks38 · neutralearnings
SINOVAC Reports Unaudited and Unreviewed Second Half of 2025 Financial Results and Files 2025 Annual Report on Form 20-F
Morningstar50 · neutralgeneral
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report | SVA Stock News
StockTitan38 · neutralgeneral